Fibromyalgia Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies – Tonix Pharmaceutical, Axsome Therapeutics, Teva Pharmaceuticals

January 16 16:54 2023
Fibromyalgia Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Tonix Pharmaceutical, Axsome Therapeutics, Teva Pharmaceuticals
The Fibromyalgia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Fibromyalgia pipeline products will significantly revolutionize the Fibromyalgia market dynamics.

DelveInsight’s “Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


The Fibromyalgia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 


To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Insights


Fibromyalgia Overview

Fibromyalgia, also known as fibromyalgia syndrome, is a prevalent and complex chronic pain illness that causes musculoskeletal pain, exhaustion, and localized soreness and has an impact on people’s emotional, physical, and social well-being. It is primarily caused by hereditary disorders. However, the exact reason is unknown.


Some of the key facts of the Fibromyalgia Market Report: 

  • The Fibromyalgia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the Worldwide Epidemiology of Fibromyalgia by Queiroz, the global mean prevalence of fibromyalgia was 2.7% and the mean rate was 3.1% in America, 2.5% in Europe while for Asia it was reported 1.7%
  • According to Dan Buskila et al., the prevalence of FM in the general population was estimated in the United States to be 2% and it affects females (3.4%) more frequently than males (0.5%)
  • According to ACR, FM was characterized by multiple symptoms in Europe and the most common reported symptoms, including widespread pain ( 62%), sleep problems (49%), and fatigue (46%)
  • Key Fibromyalgia Companies: Tonix Pharmaceutical, Axsome Therapeutics, Teva Pharmaceutical, and others
  • Key Fibromyalgia Therapies: TNX102 SL, AXS-14 (Esreboxetine), AJOVY (Fremanezumab), and others
  • The Fibromyalgia epidemiology based on gender analyzed that Fibromyalgia disease affects females more compared to males


Get a Free sample for the Fibromyalgia Market Report –


Key benefits of the Fibromyalgia Market report:

  1. Fibromyalgia market report covers a descriptive overview and comprehensive insight of the Fibromyalgia Epidemiology and Fibromyalgia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Fibromyalgia market report provides insights on the current and emerging therapies.
  3. Fibromyalgia market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Fibromyalgia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Fibromyalgia market.


Download the report to understand which factors are driving Fibromyalgia epidemiology trends @ Fibromyalgia Epidemiological Insights 


Fibromyalgia Market  

The dynamics of the Fibromyalgia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  


Fibromyalgia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.


Fibromyalgia Epidemiology Segmentation:

The Fibromyalgia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Fibromyalgia
  • Prevalent Cases of Fibromyalgia by severity
  • Gender-specific Prevalence of Fibromyalgia
  • Diagnosed Cases of Episodic and Chronic Fibromyalgia


Fibromyalgia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Fibromyalgia market or expected to get launched during the study period. The analysis covers Fibromyalgia market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Fibromyalgia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.


Discover more about therapies set to grab major Fibromyalgia market share @ Fibromyalgia market forecast 


Fibromyalgia Therapies and Key Companies

  • TNX102 SL: Tonix Pharmaceutical
  • AXS-14 (Esreboxetine): Axsome Therapeutics
  • AJOVY (Fremanezumab): Teva Pharmaceutical


Scope of the Fibromyalgia Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Fibromyalgia Companies: Tonix Pharmaceutical, Axsome Therapeutics, Teva Pharmaceuticals, and others
  • Key Fibromyalgia Therapies: TNX102 SL, AXS-14 (Esreboxetine), AJOVY (Fremanezumab), and others
  • Fibromyalgia Therapeutic Assessment: Fibromyalgia current marketed and Fibromyalgia emerging therapies
  • Fibromyalgia Market Dynamics: Fibromyalgia market drivers and Fibromyalgia market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Fibromyalgia Unmet Needs, KOL’s views, Analyst’s views, Fibromyalgia Market Access and Reimbursement 


Table of Contents 

1. Fibromyalgia Market Report Introduction

2. Executive Summary for Fibromyalgia

3. SWOT analysis of Fibromyalgia

4. Fibromyalgia Patient Share (%) Overview at a Glance

5. Fibromyalgia Market Overview at a Glance

6. Fibromyalgia Disease Background and Overview

7. Fibromyalgia Epidemiology and Patient Population

8. Country-Specific Patient Population of Fibromyalgia 

9. Fibromyalgia Current Treatment and Medical Practices

10. Fibromyalgia Unmet Needs

11. Fibromyalgia Emerging Therapies

12. Fibromyalgia Market Outlook

13. Country-Wise Fibromyalgia Market Analysis (2019–2032)

14. Fibromyalgia Market Access and Reimbursement of Therapies

15. Fibromyalgia Market Drivers

16. Fibromyalgia Market Barriers

17.  Fibromyalgia Appendix

18. Fibromyalgia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight


To know more about Fibromyalgia treatment, visit @ Fibromyalgia Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States